VivaDiag Ag SARS-Cov-2 Rapid test

 

VivaDiag™ Pro SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab, oropharyngeal swab specimen. The test is for in vitro diagnostic use only.

Specifications

  • Sensibility 97,4%
  • Specificity 100%
  • Accuracy 99,29%
  • Authorized by ANMDM

Indications:

  • For fast and easy detection of SARS-Cov-2 antigen in the accute fase of the infection. It is recommended to test within the first 5-7 days of the symptoms occurrence;
  • Differential diagnostic for influenza virus.

Steps for use:

  • Nasal/oropharyngeal specimen collection
  • Results are easy to read (2 bar system);
  • Time to results – max 15 minutes.

Kit with 25 tests, containing:

  • Individual test device x 25;
  • Buffer x 25;
  • Sample collection tube x 25;
  • Sample collection swab x 25;
  • Filter x 25.

 

Product Specification